New Search

If you are not happy with the results below please do another search

4897 search results for:

3781

New flu test: One drop of blood could save your life

Dr Benjamin Tang and his team have developed a world first test to identify which influenza patients will need urgent, life-saving, medical treatment. The High-risk Influenza Screen Test (HIST) measures ‘an early warning signal’ released by the patient’s body into their blood to ‘kick start’ their immune system’s fight against the infection. The test needs […]

3782

Genes explain higher prevalence of cardiovascular disease in chronic immune mediated inflammatory patients

The results of a study presented at the Annual European Congress of Rheumatology (EULAR) 2017 represent an important step towards characterising the genetic basis of cardiovascular disease (CVD) risk in chronic immune-mediated inflammatory diseases (IMID). Specific genetic loci (different positions on the chromosome) previously identified as being associate with CVD risk in the general population […]

3783

Siemens employees as finalists for the 2017 European Inventor Award

The European Patent Office has announced Dutch product manager Jan van den Boogaart (57) and Austrian researcher Prof. Dr. Oliver Hayden (45) as finalists for the 2017 Inventor Award in the “Industry” category. The two Siemens Healthineers employees have invented an automated method for detecting the life-threatening disease malaria. On the basis of their own […]

3784

Stago Group acquires HemoSonics LLC

The Stago Group recently announced that it has completed the acquisition of HemoSonics LLC, a company specialized in the development of innovative point-of-care testing solutions based in Charlottesville, VA, with facilities in Durham, NC (USA). With the acquisition of the patented SEER technology (Sonic Estimation of Elasticity via Resonance) and its associated Quantra™ Hemostasis Analyser, […]

3785

Studies open up possibility of immunotherapy for more cancer patients

Tens of thousands of cancer patients each year may benefit from an immunotherapy regimen called PD-1 blockade, based on results from a new clinical study. The findings establish genetic markers that help physicians identify which patients might respond to the therapy, which had been approved previously for a select few classes of cancer. "What we […]

3786

Inherited, rare skin disease informs treatment of common hair disorders

It is almost axiomatic in medicine that the study of rare disorders informs the understanding of more common, widespread ailments. Researchers from the Perelman School of Medicine at the University of Pennsylvania who study an inherited disorder of skin, hair follicles, nails, sweat glands, and teeth called hypohidrotic ectodermal dysplasia (HED) have identified a mechanism […]

3787

New blood test uses nanotechnology to predict aggressive prostate cancer accurately

A new diagnostic developed by Alberta scientists will allow men to bypass painful biopsies to test for aggressive prostate cancer. The test incorporates a unique nanotechnology platform to make the diagnostic using only a single drop of blood, and is significantly more accurate than current screening methods. The Extracellular Vesicle Fingerprint Predictive Score (EV-FPS) test […]

3788

Fasting glucose as a marker for greater weight loss on a high-fibre, low-glycemic diet

Researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University, together with colleagues from Gelesis and the University of Copenhagen, presented preliminary data demonstrating that study participants with high fasting plasma glucose lost more weight than those with low fasting plasma glucose when following a high-fibre, low-glycemic load diet. The […]

3789

Epigenetic changes at birth could explain later behaviour problems

Epigenetic changes present at birth – in genes related to addiction and aggression – could be linked to conduct problems in children, according to a new study by King’s College London and the University of Bristol. Conduct problems (CP) such as fighting, lying and stealing are the most common reason for child treatment referral in […]

3790

Five years before brain cancer diagnosis, changes detectable in blood

Interactions among proteins that relay information from one immune cell to another are weakened in the blood of brain cancer patients within five years before the cancer is diagnosed, said lead researcher Judith Schwartzbaum of The Ohio State University. That information could one day lead to earlier diagnosis of brain cancer, said Schwartzbaum, an associate […]